2011

• Clarke, S., Chua, W., Moore, M., Kao, S., Phan, V., Tan, C., Charles, K., McMillan, D. (2011), Use of inflammatory markers to guide cancer treatment. Clinical Pharmacology and Therapeutics. 90(3), 475-478. [Abstract]
• Chua, W., Kho, P., Moore, M., Charles, K., Clarke, S. (2011), Clinical, laboratory and molecular factors predicting chemotherapy efficacy and toxicity in colorectal cancer. Critical reviews in oncology/hematology. 79(3), 224-50. [Abstract]
• Chua, W., Charles, K., Baracos, V., Clarke, S. (2011), Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. British Journal of Cancer. 104(8), 1288-1295. [Abstract]

2010

• Moore, M., Chua, W., Charles, K., Clarke, S. (2010), Inflammation and cancer: causes and consequences. Clinical Pharmacology and Therapeutics. 87(4), 504-508. [Abstract]

2009

• Chua, W., Moore, M., Charles, K., Clarke, S. (2009), Predictive biomarkers of clinical response to targeted antibodies in colorectal cancer. Current Opinion in Molecular Therapeutics. 11(6), 611-622. [Abstract]
• Charles, K., Kulbe, H., Soper, R., Escorcio-Correia, M., Lawrence, T., Schultheis, A., Chakravarty, P., Thompson, R., Kollias, G., Smyth, J., Balkwill, F., Hagemann, T. (2009), The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans. Journal of Clinical Investigation. 119(10), 3011-3023. [Abstract]

2008

• Brown, E., Charles, K., Hoare, S., Rye, R., Jodrell, D., Aird, R., Vora, R., Prabhakar, U., Nakada, M., Corringham, R., DeWitte, M., Sturgeon, C., Propper, D., Balkwill, F., Smyth, J. (2008), A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer. Annals of Oncology. 19(7), 1340-1346. [Abstract]
• Hagemann, T., Lawrence, T., McNeish, I., Charles, K., Kulbe, H., Thompson, R., Robinson, S., Balkwill, F. (2008), "Re-educating" tumor-associated macrophages by targeting NF-kappaB. The Journal of Experimental Medicine. 205(6), 1261-1268. [Abstract]
• Morgan, E., Goralski, K., Piquette-Miller, M., Renton, K., Robertson, G., Chaluvadi, M., Charles, K., Clarke, S., Kacevska, M., Liddle, C., Richardson, T., Sharma, R., Sinal, C. (2008), Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metabolism and Disposition. 36(2), 205-216. [Abstract]

2007

• Harrison, M., Obermueller, E., Maisey, N., Hoare, S., Edmonds, K., Li, N., Chao, D., Hall, K., Lee, C., Timotheadou, E., Charles, K., Ahern, R., King, D., Eisen, T., Corringham, R., DeWitte, M., Balkwill, F., Gore, M. (2007), Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose. Journal of clinical oncology. 25(29), 4542-4549. [Abstract]
• Hagemann, T., Robinson, S., Thompson, R., Charles, K., Kulbe, H., Balkwill, F. (2007), Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis. Molecular cancer therapeutics. 6(7), 1993-2002. [Abstract]

2006

• Charles, K., Rivory, L., Brown, S., Liddle, C., Clarke, S., Robertson, G. (2006), Transcriptional repression of hepatic cytochrome P450 3A4 gene in the presence of cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 12(24), 7492-7. [Abstract]
• Hagemann, T., Wilson, J., Burke, F., Kulbe, H., Li, N., Plüddemann, A., Charles, K., Gordon, S., Balkwill, F. (2006), Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. Journal of immunology. 176(8), 5023-5032. [Abstract]
• Szlosarek, P., Charles, K., Balkwill, F. (2006), Tumour necrosis factor-alpha as a tumour promoter. European journal of cancer. 42(6), 745-750. [Abstract]
• Charles, K., Rivory, L., Stockler, M., Beale, P., Beith, J., Boyer, M., Clarke, S. (2006), Predicting the toxicity of weekly docetaxel in advanced cancer. Clinical pharmacokinetics. 45(6), 611-22. [Abstract]